By www.reliableresearchiq.com
Global Short Bowel Syndrome (SBS) Drugs Market Research Report 2024 Story
89
$ 2900
Short Bowel Syndrome (SBS) Drugs Report report is categorised based on following features:
1. Global Market Players
2. Geopolitical regions
3. Consumer Insights
4. Technological advancement
5. Historic and Future Analysis of the Market
Merck Takeda Emmaus Medical Ardelyx Naia Pharmaceuticals Nutrinia OxThera Sancilio Pharmaceuticals Zealand Pharma